Gilead Sciences (GILD)
$68.28
0.10 (0.15%)
GILD Stock Quote Delayed 30 Minutes
Previous Close
$68.18
Market Cap
88.78B
PE Ratio
25.96
EPS
2.63
Volume (Avg. Vol.)
1.08M
Day's Range
68.00 - 68.48
52-Week Range
60.89 - 85.97
Dividend & Yield
2.23 (3.27%)
GILD Stock Predictions, Articles, and Gilead Sciences News
Stock Market Today: Huge Jobs Miss; Amazon Prime Day Delay
Stocks slipped, but didn't plummet in the stock market today despite a horrendous jobs report that highlight the impact of Covid-19.
Gilead Sciences’ Coronavirus Treatment Has Big-Time Potential
Gilead Sciences is working on a coronavirus treatment, while GILD stock works on a breakout. Let's examine it more closely.
GILD Stock Remains a Smart Play Now and in the Future
Gilead Science’s clinical trial for remdesivir continues. With or without it, GILD stock remains a smart play.
Gilead’s Cash and the Coronavirus Make GILD Stock Look Cheap
Gilead Sciences rose to prominence with its hepatitis C drug. Now GILD stock is soaring on hopes for a coronavirus treatment.
Stock Market Today: Healthcare Stocks Leads the Way; Buy Zoom?
Healthcare stocks lead the way higher on Monday, as equities added another gain to the recent run. Here's the stock market today.
This PR Nightmare for GILD Stock Will Eventually Fade
Once touted as a direct coronavirus play, GILD stock is now receiving heat due to a PR nightmare. But this unfortunate development ultimately won’t affect the bigger picture.
Gilead Stock Flies High With a Potential Coronavirus Treatment
GILD stock could skyrocket if it is first in the door to provide an effective treatment for the coronavirus with its remdesivir drug.
Stock Market Today: Time for Some Good News; Automotive Drama
Stocks hit new 52-week lows in the stock market today, as equities continue to free-fall on coronavirus-related worries.
Gilead Sciences Stock: Still Cheap but Don’t Count On a Coronavirus Rally
Gilead Sciences has scored a lot of attention with its drug that may treat coronavirus. That doesn't necessarily make GILD stock a buy yet, though.
GT Biopharma News: GTBP Stock Spikes 26% on Coronavirus Treatment Hopes
GT Biopharma (GTBP) news for Tuesday about it working on a possible treatment for the coronavirus from China has GTBP stock heading higher.
GILD Stock Looks Poised for a Serious Coronavirus Bump
There's a good chance that Gilead's drug will become the coronavirus vaccine, making Gilead stock attractive.
Stock Market Today: Jobs Beat Doesn’t Matter; VIX to Decade High
The VIX topped $50 and hit its highest level in a decade. Here's what else happened in the stock market today.
4 Top Stock Trades for Monday: AMD, WMT, CRM, GILD
Advanced Micro Devices, Walmart, Gilead Sciences and Salesforce were our top stock trades for Monday. That said, here's a look at the charts.
Is Inovio Stock a Buy on Coronavirus Cure Potential?
INO stock has screamed higher on the possibility of a coronavirus vaccine but the underlying company isn't the most fiscally stable.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
